A Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of Schizophrenia
Public ClinicalTrials.gov record NCT01234779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Multi-center, Randomized, 4-week, Double-blind, Parallel Group, Placebo and Active-controlled Trial of the Safety and Efficacy of RO4917838 vs. Placebo in Patients With an Acute Exacerbation of Schizophrenia
Study identification
- NCT ID
- NCT01234779
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Enrollment
- 301 participants
Conditions and interventions
Conditions
Interventions
- bitopertin [RO4917838] Drug
- olanzapine Drug
- placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2011
- Primary completion
- Aug 31, 2012
- Completion
- Aug 31, 2012
- Last update posted
- Nov 1, 2016
2011 – 2012
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Little Rock | Arkansas | 72201 | — |
| Not listed | Cerritos | California | 90703 | — |
| Not listed | Oceanside | California | 92056 | — |
| Not listed | Pico Rivera | California | 90660 | — |
| Not listed | San Diego | California | 92121 | — |
| Not listed | Lauderhill | Florida | 33021 | — |
| Not listed | North Miami | Florida | 33161 | — |
| Not listed | Atlanta | Georgia | 30308 | — |
| Not listed | Lake Charles | Louisiana | 70601 | — |
| Not listed | Flowood | Mississippi | 39232 | — |
| Not listed | St Louis | Missouri | 63141 | — |
| Not listed | Willingboro | New Jersey | 08046 | — |
| Not listed | Holliswood | New York | 11423 | — |
| Not listed | New York | New York | 11004 | — |
| Not listed | Cincinnati | Ohio | 45219 | — |
| Not listed | Philadelphia | Pennsylvania | 19139 | — |
| Not listed | Charlesston | South Carolina | 29405 | — |
| Not listed | Austin | Texas | 78754 | — |
| Not listed | Irving | Texas | 75062 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01234779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 1, 2016 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01234779 live on ClinicalTrials.gov.